Cookies and the protection of your data

We use cookies to improve the functionality of the website, to offer you a better website experience and to provide social media features. You give your consent by clicking on “Accept all Cookies” or as part of your individual settings. Please find detailed information on the use of cookies on this website in our Data Privacy Statement.

Functional Cookies

These cookies are necessary for the operation of the site and enable security-relevant functions. In addition, we determine whether you want to remain logged in and to make our services available to you when you change between this and other websites.

Statistical Cookies

These cookies are used for analyzing user behavior on our website with the aim of improving user navigation. All data collected is evaluated anonymously. Further information is available on our data protection site.

Marketing Cookies

These cookies are used to deliver relevant advertising or to limit how many times you see an ad. Marketing cookies can share that information with the advertiser (third-party cookies). The legal basis for the data processing is the consent of the user.

BubbleJect K+ Device
BubbleJect K+ Device
BubbleJect K+ Device
BubbleJect K+ Device
BubbleJect K+ Device
BubbleJect K+ Device
BubbleJect K+ Device
BubbleJect K+ Device
BubbleJect K+ Device
BubbleJect K+ Device
BubbleJect K+ Device
BubbleJect K+ Device
BubbleJect K+ Device
BubbleJect K+ Device
2026

Share:

BubbleJect K+ Device

Low Cost Pre-Filled Injectable Medicine Device

In low resource settings, injectable medicines traditionally rely on multi-dose glass vials and syringes, demanding sterile environments, trained staff, and time – often unavailable in rural clinics. This causes wastage, contamination risks, and delays, reducing global access to care. BubbleJect provides a solution by offering an affordable, safe, single-use device with reuse-prevention features, an intuitive design, and integrated Blow-Fill-Seal technology. Compatible with drug manufacturers and last-mile delivery, it simplifies administration, and empowers the end user and health workers. Our project is supported by The Gates Foundation.

Client / Manufacturer

Gates Foundation

Seattle, Washington, US

Rommelag SE & Co. KG

Sulzbach-Laufen, DE
Design

ApiJect Research UK LTD

London, GBMarc Koska, Max Hannon, Maria Inacio, George Fryett
Date of Launch
2026
Target Regions
Africa, Asia, South America
Target Groups
Consumers / Users, Public Sector / Government

RELATED PROJECTS